Successful treatment of Paecilomyces variotii peritonitis in a liver transplant patient

Mycopathologia. 2015 Apr;179(3-4):317-20. doi: 10.1007/s11046-014-9854-1. Epub 2014 Dec 23.

Abstract

Paecilomyces variotii has previously been reported as a causative pathogen for peritonitis in patients on continuous ambulatory peritoneal dialysis and shown to be usually sensitive to amphotericin B and resistant to voriconazole. We report the first case, to our knowledge, of P. variotii peritonitis in a liver transplant patient, which was unresponsive to initial liposomal amphotericin B (L-AmB) treatment and resolved dramatically after the addition of voriconazole. The present case provides evidence for the clinical and microbiological effectiveness of voriconazole combined with L-AmB in treating P. variotii peritonitis refractory to initial L-AmB treatment.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antifungal Agents / administration & dosage
  • Humans
  • Liver Transplantation / adverse effects*
  • Male
  • Mycoses / drug therapy*
  • Mycoses / microbiology
  • Paecilomyces / drug effects*
  • Paecilomyces / genetics
  • Paecilomyces / isolation & purification
  • Peritonitis / drug therapy*
  • Peritonitis / microbiology
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / microbiology
  • Voriconazole / administration & dosage

Substances

  • Antifungal Agents
  • Voriconazole